이상남 (성균관대학교 나노과학기술원 (SAINT))님 | 한빛사연구자 > 한빛사

성균관대학교 나노과학기술원 (SAINT)

최종업데이트 2024.11.07.

Focused ultrasound-triggered doxorubicin liposomes reshape tumor microenvironment to boost checkpoint depletion in triple-negative breast cancer model
- J. Control. Release, Available online 4 November 2025, 114389 | https://doi.org/10.1016/j.jconrel.2025.114389
- 2025-11
- 바이오·의료융합
- 한빛사논문
Kinetically activating nanovaccine mimicking multidimensional immunomodulation of natural infection for broad protection against heterologous viruses in animal models
- Nat. Commun., Published: 25 March 2025 | https://doi.org/10.1038/s41467-025-58006-y
- 2025-03
- 의약학
- 한빛사논문
Virulence-Free Reconstituted Synthetic Nanopathogen Empowered by Timely-Activating TLR Agonist Promotes Heterologous Cancer Immunotherapy with Depletion of Tumor-Specific Treg Cells
- Adv. Funct. Mater., 03 November 2024 | https://doi.org/10.1002/adfm.202411747
- 2024-11
- 의약학
- 한빛사논문
Overcoming Chemoimmunotherapy-Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension
- Adv. Sci., First published: 07 August 2021 | https://doi.org/10.1002/advs.202102043
- 2021-08
- 바이오·의료융합
- 한빛사논문
Chemical Strategies to Enhance the Therapeutic Efficacy of Toll-like Receptor Agonist Based Cancer Immunotherapy
- Acc. Chem. Res., Publication Date:September 23, 2020, 53, 10, 2081-2093 | https://doi.org/10.1021/acs.accounts.0c00337
- 2020-09
- 바이오·의료융합
- 한빛사논문

연구자 ID

저자논문